Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
This funding opportunity supports researchers investigating how certain diabetes medications may influence cancer risk, particularly in relation to obesity-related cancers, through innovative mechanistic studies.
$275,000
Closed
Nationwide
Key Dates
Application Opens
August 24, 2023
Application Closes
November 17, 2024
Contact Information
Grantor
NIH Grants Information
Subscribe to view contact details
Newsletter Required
Categories
Education
Health
